8 min

Risky Business: PD-1 Immune Checkpoint Blockade in Thymic Epithelial Neoplasms Journal of Clinical Oncology (JCO) Podcast

    • Science

This podcast discusses the important risks and potential benefits of PD-1 immune checkpoint blockade in patients with thymic epithelial neoplasms.
Read the related article "Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial" on JCO.org

  • Copyright by the American Society of Clinical Oncology

This podcast discusses the important risks and potential benefits of PD-1 immune checkpoint blockade in patients with thymic epithelial neoplasms.
Read the related article "Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial" on JCO.org

8 min

  • Copyright by the American Society of Clinical Oncology

Top Podcasts In Science

Hidden Brain
Hidden Brain
Hidden Brain, Shankar Vedantam
Radiolab
Radiolab
WNYC Studios
Something You Should Know
Something You Should Know
Mike Carruthers | OmniCast Media | Cumulus Podcast Network
Making Sense with Sam Harris
Making Sense with Sam Harris
Sam Harris
Ologies with Alie Ward
Ologies with Alie Ward
Alie Ward
StarTalk Radio
StarTalk Radio
Neil deGrasse Tyson